ATE76301T1 - Nachweis aktivierter blutplaettchen mittels antikoerper gegen zelloberflaechenantigene. - Google Patents

Nachweis aktivierter blutplaettchen mittels antikoerper gegen zelloberflaechenantigene.

Info

Publication number
ATE76301T1
ATE76301T1 AT86902245T AT86902245T ATE76301T1 AT E76301 T1 ATE76301 T1 AT E76301T1 AT 86902245 T AT86902245 T AT 86902245T AT 86902245 T AT86902245 T AT 86902245T AT E76301 T1 ATE76301 T1 AT E76301T1
Authority
AT
Austria
Prior art keywords
receptor
stimulated
platelet
antigen
plalettes
Prior art date
Application number
AT86902245T
Other languages
English (en)
Inventor
Mark H Ginsberg
Edward F Plow
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Application granted granted Critical
Publication of ATE76301T1 publication Critical patent/ATE76301T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/806—Electrical property or magnetic property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT86902245T 1985-04-04 1986-03-25 Nachweis aktivierter blutplaettchen mittels antikoerper gegen zelloberflaechenantigene. ATE76301T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/720,032 US4820505A (en) 1985-04-04 1985-04-04 Detection of activated platelets with antibodies to thrombospondin
PCT/US1986/000616 WO1986005693A1 (en) 1985-04-04 1986-03-25 Detection of activated platelets with antibodies to cell surface antigens
EP86902245A EP0216864B1 (de) 1985-04-04 1986-03-25 Nachweis aktivierter blutplättchen mittels antikörper gegen zelloberflächenantigene

Publications (1)

Publication Number Publication Date
ATE76301T1 true ATE76301T1 (de) 1992-06-15

Family

ID=24892375

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86902245T ATE76301T1 (de) 1985-04-04 1986-03-25 Nachweis aktivierter blutplaettchen mittels antikoerper gegen zelloberflaechenantigene.

Country Status (10)

Country Link
US (1) US4820505A (de)
EP (1) EP0216864B1 (de)
JP (1) JP2752614B2 (de)
AT (1) ATE76301T1 (de)
CA (1) CA1264029A (de)
DE (1) DE3685390D1 (de)
DK (1) DK173787B1 (de)
ES (1) ES8801439A1 (de)
NO (1) NO170128C (de)
WO (1) WO1986005693A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225181A (en) * 1985-06-07 1993-07-06 The Research Foundation Of State University Of New York Radiolabeled antiplatelet monoclonal antibody for imaging in-vivo thrombi
NO884566L (no) * 1987-10-15 1989-04-17 Univ Moskovsk Anvendelse av fluorderivater og kontrastpreparat for diagnostisering av ondartede neoplasmer.
US5372933A (en) * 1988-10-03 1994-12-13 The Scripps Research Institute Polypeptides that mimic receptor-induced binding sites, and methods of using same
US5024829A (en) * 1988-11-21 1991-06-18 Centocor, Inc. Method of imaging coronary thrombi
US5026537A (en) * 1989-04-06 1991-06-25 Centocor, Inc. Methods for imaging atherosclerotic plaque
US5185142A (en) * 1989-07-28 1993-02-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antigen-specific composition and in vivo methods for detecting and localizing an antigenic site and for radiotherapy
US5116599A (en) * 1989-07-31 1992-05-26 Johns Hopkins Univ. Perfluoro-t-butyl-containing compounds for use in fluorine-19 nmr and/or mri
WO1991006858A1 (en) * 1989-11-03 1991-05-16 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Novel monoclonal antibody against human platelets
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
DE4040817A1 (de) * 1989-12-27 1991-07-04 Boehringer Ingelheim Int Verwendung eines antikoagulant als diagnostikum
US5192744A (en) * 1990-01-12 1993-03-09 Northwestern University Method of inhibiting angiogenesis of tumors
US5196309A (en) * 1990-11-15 1993-03-23 The Scripps Research Institute Characterization of platelet aggregation disorders
US5844097A (en) * 1990-11-30 1998-12-01 Monoclonetics International, Inc. Methods for the diagnosis of peripheral nerve damage
ES2083152T3 (es) * 1990-11-30 1996-04-01 Monoclonetics Int Metodos para el diagnostico de dolores cronicos lumbares y cervicales.
US5256538A (en) * 1991-03-08 1993-10-26 Board Of Regents, The University Of Texas System Detection of early platelet activation and prediagnosis of thrombotic events
US5807745A (en) * 1991-03-11 1998-09-15 New England Medical Center Hospitals, Inc. Method of inhibiting PADGEM-mediated or ELAM-1-mediated leukocyte adhesion using an inhibitor comprising a Lex core component
US5364612A (en) * 1991-05-06 1994-11-15 Immunomedics, Inc. Detection of cardiovascular lesions
SE469451B (sv) * 1991-06-28 1993-07-05 Anders Larsson Karakterisering eller bestaemning av maengden mammalieceller medelst antikroppar
WO1993007174A1 (en) * 1991-10-01 1993-04-15 The General Hospital Corporation Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto
US5457028A (en) * 1992-04-22 1995-10-10 Milwaukee Heart Research Foundation Standard platelet samples and method for preparation thereof
JP3381172B2 (ja) 1993-01-26 2003-02-24 アラーガン、インコーポレイテッド コンタクトレンズ消毒用組成物および方法
US5968477A (en) * 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
US20030220233A1 (en) * 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US6159443A (en) * 1999-04-29 2000-12-12 Vanderbilt University X-ray guided drug delivery
US7049140B1 (en) 1999-04-29 2006-05-23 Vanderbilt University X-ray guided drug delivery
US7306925B2 (en) 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
US7029468B2 (en) * 2002-06-25 2006-04-18 Enpath Medical, Inc. Catheter assembly with side wall exit lumen and method therefor
US7655411B2 (en) * 2002-08-23 2010-02-02 W2 Holdings, Inc. Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
US10449261B2 (en) 2014-07-24 2019-10-22 Washington University Compositions targeting radiation-induced molecules and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3789116A (en) * 1970-12-09 1974-01-29 Abbott Lab Fluorescent labeled antibody reagent
US4385046A (en) * 1980-12-15 1983-05-24 Minnesota Mining And Manufacturing Company Diagnostic radio-labeled polysaccharide derivatives
JPS6058927A (ja) * 1983-09-09 1985-04-05 Nippon Mejifuijitsukusu Kk 放射能標識血小板製剤
US4610960A (en) * 1983-12-21 1986-09-09 Wisconsin Alumni Research Foundation Monoclonal antibody to thrombospondin and method for assaying for and isolating thrombospondin
US4783330A (en) * 1984-11-15 1988-11-08 New England Medical Center Hospitals, Inc. Monoclonal antibodies to activated platelets

Also Published As

Publication number Publication date
NO864872L (no) 1986-12-04
EP0216864A4 (de) 1989-09-26
WO1986005693A1 (en) 1986-10-09
US4820505A (en) 1989-04-11
DK581386A (da) 1986-12-03
CA1264029A (en) 1989-12-27
DK581386D0 (da) 1986-12-03
DE3685390D1 (de) 1992-06-25
NO864872D0 (no) 1986-12-04
NO170128B (no) 1992-06-09
EP0216864B1 (de) 1992-05-20
EP0216864A1 (de) 1987-04-08
NO170128C (no) 1992-09-16
JPS62502964A (ja) 1987-11-26
ES8801439A1 (es) 1987-12-16
DK173787B1 (da) 2001-10-22
JP2752614B2 (ja) 1998-05-18
ES553738A0 (es) 1987-12-16

Similar Documents

Publication Publication Date Title
ATE76301T1 (de) Nachweis aktivierter blutplaettchen mittels antikoerper gegen zelloberflaechenantigene.
Matioli et al. Electrophoresis of hemoglobin in single erythrocytes
DE3854496D1 (de) Peptide und antikörper, die die bindung von blutplättchen verhindern.
ATE159982T1 (de) Antikörper mit modifiziertem kohlenhydratgehalt und verfahren zur herstellung und verwendung
Saxinger et al. Methods in laboratory investigation. Application of the indirect enzyme-linked immunosorbent assay microtest to the detection and surveillance of human t cell leukemia-lymphoma virus
ES2082777T3 (es) Un metodo para la deteccion de un anti-cuerpo y antigeno en un inmunoensayo.
BRPI0405215B1 (pt) elemento de teste na forma de uma tira de teste imunocromatográfico e método para detectar o peptídeo natriurético procerebral de terminal n
JPS6091263A (ja) 体液中蛋白質の免疫学的定量法
ATE123340T1 (de) Diagnostischer nachweis unter verwendung von chimären antikörpern.
DE3883073D1 (de) Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aus einer der immunglobulin-klassen a, m, d oder e und dazu geeignetes mittel.
Springer et al. Cell adhesion molecules: detection with univalent second antibody.
Crowle et al. Preparatory Electroimmunodiffusion for Making Prepitins to Selected Native Antigens
Grey et al. Immunoglobulins on the Surface of Lymphocytes: V. Quantitative Studies on the Question of Whether Immunoglobulins Are Associated with T Cells in the Mouse
Minden et al. A comparison of seven procedures to detect the primary binding of antigen by antibody
EP0232179A3 (en) Assay for human breast cancer
DK199783A (da) Immunoglobulin-halvmolekyler og fremgangsmaade til fremstilling af hybrid-antistoffer
Stevens et al. Immunochemical and electrophoretic properties of oestrous rabbit uterine fluid proteins obtained by uterine ligation
ATE102357T1 (de) Verfahren zur bestimmung von fuer ein antigen klassenspezifischen antikoerpern und dazu geeignetes reagenz.
ATE188551T1 (de) Feststellung von antikörperproduktion
SE7703918L (sv) Sett att framstella l-l-antikropp, rening av l-l-antigen och reagens for pavisande av l-l-antikropp och l-l-antigen
DE3686717D1 (de) Immuntestverfahren.
BARNHART Immunologic techniques
KR870002453A (ko) 프로좀 단백질에 대한 단일항체의 제조방법 및 그를 이용한 프로좀과 관련된 현상의 검출 및 질병의 진단법
ATE184286T1 (de) Hgpiib-fragmente und ihre verwendung in in-vitro- verfahren zur bestimmung von in vivo stattfindenden thrombotischen ereignissen
Das et al. Rapid Identification of Hepatitis Associated Antigen and Antibody by Counter‐Immunoelectroosmophoresis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time